Table 1 Patient characteristics
Characteristics | N = 20 |
|---|---|
Epidemiology | |
Age, y, mean ± SD | 31 ± 8 |
Female gender, n (%) | 20 (100) |
Previous SLE manifestations | |
Skin, n (%) | 11 (55) |
Joints, n (%) | 9 (45) |
Serositis, n (%) | 4 (20) |
Kidney, n (%) | 11 (55) |
Central nervous system, n (%) | 1 (5) |
SELENA-SLEDAI at Day 0, mean (range) | 2 (0 to 8) |
25-Hydroxyvitamin D levels | |
Mean ± SD, ng/mL | 22 ± 11 |
25(OH)D ≤ 10 ng/mL, n (%) | 1 (5) |
11 < 25(OH)D ≤ 20 ng/mL, n (%) | 11 (55) |
21 < 25(OH)D ≤ 30 ng/mL, n (%) | 8 (40) |
Associated treatments* | |
Prednisone, n (%) | 14 (70) |
Prednisone, median, mg/day (range) | 5 (0 to 15) |
Hydroxychloroquine, n (%) | 17 (85) |
Azathioprine, n (%) | 2 (10) |
Mycophenolate mofetil, n (%) | 1 (5) |